206TiP SIERRA: A phase IIIb, single-arm, multicentre study of tremelimumab plus durvalumab for first-line treatment of advanced unresectable hepatocellular carcinoma

作者：S.L. Chan, B. Sangro, Masatoshi Kudo, Aaron Dane, Corinne Emery, Michael J. Paskow, M. Makowsky, B. Nguyen, Lorenza Rimassa · 发表于：Annals of Oncology · 年份：2023 · DOI：10.1016/j.annonc.2023.10.785 · 被引用次数：7 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Cancer, Hypoxia, and Metabolism